AC-170
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AC-170, covering 2017-08-30 to 2017-08-30. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model [Phase 2, Phase 3]